Aarti Pharmalabs has recently informed exchanges that the company reopened its Vapi plant after Gujarat Pollution Control Board (GPCB) revoked closure directions. The revocation, effective for three months from January 17, 2025, follows compliance with GPCB procedures.
The company has paid an Interim Environmental Damage Compensation of ₹3,40,000 as part of the resolution process. Located at Plot No. 22/C-1, Phase 1, GIDC Vapi, the plant is now preparing to resume operations.
Aarti Pharmalabs assures stakeholders that this development will not have any significant financial or operational impact. The company remains committed to maintaining regulatory compliance and sustainable operations.
In the meantime, Aarti Pharmalabs shares closed at ₹659.00 on Friday, slightly above the opening price of ₹657.90. The stock reached an intraday high of ₹667.30 and a low of ₹653.80. Its 52-week high is ₹721.70, while the low is ₹399.55, showcasing significant yearly volatility.
